Skip to main content
. 2021 Nov 11;12:770580. doi: 10.3389/fphar.2021.770580

TABLE 4.

Analysis of the Cox regression results in the CTRCD and non-CTRCD groups.

B SE Wals p HR (95.0% CI)
L2v (%) 0.123 0.116 1.116 0.291 1.131 (0.9–1.42)
G2v (%) 0.082 0.032 6.616 0.01* 1.086 (1.02–1.156)
I2v (%) 0.013 0.028 0.21 0.646 1.013 (0.958–1.071)
S2v (%) 3.847 2.085 3.403 0.065 46.854 (0.786–2791.451)
C2v (%) 5.512 2.299 5.75 0.016* 247.692 (2.737–22419.074)
A2v (%) −0.053 2.969 0 0.986 0.949 (0.003–319.475)
BMI (kg/m2) 0.263 0.133 3.914 0.048* 1.301 (1.002–1.688)
BSA (m2) 0.849 2.775 0.094 0.76 2.336 (0.01–537.464)
LDL-C (mmol/L) 0.567 1.287 0.194 0.66 1.763 (0.142–21.945)
TC (mmol/L) −0.054 0.905 0.004 0.953 0.948 (0.161–5.589)

SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; BMI, body mass index; BSA, body surface area; Glu, blood glucose; TG, triglycerides; TC, total cholesterol; L2v, rate of change of LVEF at T2; G2v, rate of change of GLS at T2; I2v, rate of change of GWI at T2; E2v, rate of change of GWE at T2; S2v, rate of change of 3D-GLS at T2; C2v, rate of change of 3D-GCS at T2; A2v, in the rate of change of 3D-GAS at T2. *p < 0.05.